At a Glance

We are committed to providing innovative and efficacious products for the self-care market for people who want to lead a healthier life.

What we do

Venture Life develops, manufactures and distributes products for the self-care market. These are non-drug products that consumers buy without prescription to help lead a healthier life.

There is a growing demand for self-care products due to an ageing population. People are living longer and taking more interest and responsibility for their health, with an increased focus on preventative wellness. This approach of increased personal responsibility can deliver improved health and well-being in the short, medium and long term for individuals.

Business model

Based on a vertically integrated approach, we either acquire or develop in-house self-care products, that are manufactured in our factory; these are then distributed either directly to retail outlets or through global distribution partnerships.

SustainableprofitabilityAcquire ordevelopManufacture(own brandsand customerbrands)DistributeB2B

Our strategy

We want to become a leading global self-care branded products business. With our own expertise in development, manufacturing and international distribution, growth will come from the following:

Revenue growth fromproduct acquisitionProfit growth throughimproving marginsRevenue growth fromexisting and newdistribution partnersRevenue growthfrom developinginnovative products4 Key Growth Drivers of the Business

Our products

Venture Life has its own portfolio of self-care products, which are sold without prescription through pharmacies and other retailers. They address a wide range of healthcare issues from oral healthcare, women’s intimate health, neurology, cardiovascular and dermatology.

Many of our products have intellectual property including trademarks, patents clinical evidence proving efficacy as well as formulation and manufacturing expertise. Being a non-drug company means faster regulatory routes to market and lower regulatory costs.

Distribution

100+Partners
44Markets worldwide

UK

Within the UK, the acquisition of the UltraDEX and more recently the Dentyl brand has given us direct access to the UK retail market including key retailers such as Boots, Tesco and Amazon. In the UK this direct route earns us higher revenues per unit, and we invest this extra money in UK consumer marketing to support the products.

International

Our international business follows a B2B model. We partner our own brands with reputable pharmaceutical or healthcare partners around the world, focusing on key markets.

Our partners have local market expertise and the partner covers all in-market costs, so we have no exposure to funding, sales and marketing costs.

 

Key partners

UK

International

Key milestones

2010Acquisition ofOriginal Bioscalinbrand2014Acquisition ofBiokosmes Srl, anItalian developmentand manufacturingbusiness; yearof IPO2016Acquisition ofPeriproducts Ltd,includingUltraDEX brand2017FDA OTC drugmanufacturingcompliance for theUS market2018Acquisition ofDentyl brand2010Venture Lifeco-founded byJerry Randall andSharon Collins